DEFTA PARTNERS
DEFTA Partners is a venture capital firm focusing on technology. They primarily make seed and first round investments in early stage information technology companies with global opportunities to accelerate growth. DEFTA has offices and partners in the United States, Japan, Israel and the United Kingdom. via: [DEFTA Partners](http://www.deftapartners.com)
DEFTA PARTNERS
Industry:
Information Technology Venture Capital
Founded:
1984-01-01
Status:
Active
Contact:
(415) 433-2262
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Google Cloud Sectigo SSL Sectigo Domain SSL
Similar Organizations
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Underscore VC
Underscore VC is a venture capital firm backing entrepreneurs from Seed to Series A.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-13 | Endogena | DEFTA Partners investment in Series A - Endogena | 21 M USD |
| 2021-08-24 | DiA Imaging Analysis | DEFTA Partners investment in Venture Round - DiA Imaging Analysis | 14 M USD |
| 2021-03-16 | Acepodia | DEFTA Partners investment in Series B - Acepodia | 47 M USD |
| 2021-01-28 | Endogena | DEFTA Partners investment in Series A - Endogena | 8 M USD |
| 2020-09-29 | Aegle Therapeutics | DEFTA Partners investment in Series A - Aegle Therapeutics | 6.5 M USD |
| 2020-06-26 | InformAI | DEFTA Partners investment in Seed Round - InformAI | 1.8 M USD |
| 2020-06-23 | TARA Biosystems | DEFTA Partners investment in Series A - TARA Biosystems | 10 M USD |
| 2020-02-21 | 1World Online | DEFTA Partners investment in Series A - 1World Online | 8.48 M USD |
| 2020-01-09 | Aegle Therapeutics | DEFTA Partners investment in Series A - Aegle Therapeutics | 4 M USD |
| 2019-11-12 | Actuate Therapeutics | DEFTA Partners investment in Series B - Actuate Therapeutics | 6.5 M USD |